查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1934196

心臟監測和心律管理設備市場 - 全球產業規模、佔有率、趨勢、機會、預測（按心臟監測設備、心律管理設備、最終用戶、地區和競爭格局分類，2021-2031）

Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Cardiac Monitoring Devices, By Cardiac Rhythm Management Devices, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球心臟監測和心律管理設備市場預計將從 2025 年的 263.8 億美元成長到 2031 年的 375.3 億美元，複合年成長率為 6.05%。

這些技術包括旨在透過電療或持續監測來調節心臟活動或檢測心律不整的醫療設備。推動市場成長的主要因素是慢性心血管疾病盛行率的不斷上升和人口老化，這需要持續的生理監測。根據歐洲心臟學會 (ESC) 2024 年的報告，心血管疾病仍將是成員國的主要死因，每年造成超過 300 萬人死亡。這一重大健康問題的沉重負擔凸顯了開發能夠預防不良心臟事件的治療和診斷解決方案的必要性。

市場概覽
預測期 2027-2031
市場規模：2025年 263.8億美元
市場規模：2031年 375.3億美元
複合年成長率：2026-2031年 6.05%
成長最快的細分市場 心電圖（ECG）設備
最大的市場 北美洲

然而，高昂的產品開發成本和各醫療體系嚴格的報銷機制嚴重阻礙了市場擴張。這些監管和財務障礙常常延緩新技術的商業性化應用，尤其是在成本敏感領域，並限制了患者獲得先進治療方案的機會。因此，這些障礙造成了一個複雜的環境，創新步伐往往受到財務和合規相關因素的限制。

市場促進因素

全球心血管疾病和心律不整盛行率的不斷上升是推動全球心臟監測和心律管理設備市場發展的關鍵因素。隨著慢性心臟病負擔的加重，早期發現心律不整和持續生理監測對於降低死亡風險至關重要。這種日益成長的需求與肥胖等生活方式相關危險因子的流行密切相關，這些危險因子會顯著加劇心血管疾病的易感性。世界心臟聯盟於2025年5月發布的《2025年世界心臟報告》顯示，目前全球約十分之一的心血管疾病死亡病例是由高體重指數（BMI）導致的，這凸顯了有效管理的必要性。此外，美國心臟協會於2025年1月發布的《2025年心臟病和中風統計》指出，2021年全球約有1,941萬人死於心血管疾病，顯示有大量患者需要介入。

同時，無導線和微創心臟節律管理解決方案的興起正在改變市場格局，為傳統的經靜脈系統提供了更安全、以患者為中心的替代方案。脈衝電場消融和無導線心律調節器等創新技術正迅速普及，因為它們最大限度地減少了手術併發症並縮短了恢復時間。隨著醫療機構積極採用這些先進的微創技術，這項轉變正在推動顯著的商業性成長。例如，波士頓科學公司在2025年2月發布的「2024年第四季及全年財務業績」報告中指出，其第四季淨銷售額成長了22.4%。這一快速成長主要得益於該公司尖端節律管理和介入性心臟病學產品組合的快速普及。

市場挑戰

產品研發的高昂成本和嚴格的報銷機制是全球心臟監測和節律管理設備市場擴張的主要障礙。開發複雜的III類醫療器械，例如連續監測儀和植入式心臟整流去顫器（ICD），需要大量的資金投入以滿足臨床試驗要求和監管標準。這些要求，加上柔軟性的報銷政策（這些政策經常限制或延遲新興技術的保險覆蓋），給製造商帶來了沉重的財務負擔。這種經濟壓力抑制了創新投資，迫使企業將資源用於合規而非研發，最終延緩了關鍵心臟解決方案的商業化。

這些監管和財務壁壘直接阻礙了先進療法在關鍵地區的推廣應用。為了避免成本過高，製造商擴大推遲在合規要求複雜的市場推出產品。根據歐洲醫療技術協會（MedTech Europe）2024年的數據，由於歐盟監管環境資源密集且難以預測，主要醫療設備製造商選擇歐盟作為其主要上市市場的比例下降了33%。這些市場准入延遲抑制了全球該行業的成長，並限制了患者獲得必要的心臟節律管理療法的機會。

市場趨勢

將人工智慧融入預測分析和即時心電圖分析，從根本上改變了診斷工作流程，提高了心律不整檢測的準確性和速度。這項技術進步超越了簡單的數據存儲，利用深度學習演算法來識別傳統監測方法常常忽略的細微生理模式，從而實現更早的醫療干預。監管機構正在加快核准這些軟體主導的解決方案，這表明整個行業對演算法決策的信心日益增強。正如2025年1月《心血管商業》雜誌的一篇文章《FDA核准超過1000個AI模型》中報導，過去兩個月內，有10種新的心臟病學專用AI演算法核准，使心臟病學成為演算法創新領域第二大領域。

同時，家庭監測解決方案和遠端心臟遙測技術的興起進一步分散了醫療服務的使用，使得患者能夠在臨床環境之外進行持續監測。這一趨勢的驅動力在於，需要利用穿戴式的、不引人注意的貼片技術來提高患者依從性並降低再入院率，該技術可將數據直接傳輸給醫療服務提供者。這些攜帶式平台的商業性成功表明，人們越來越依賴診所以外的增強診斷服務。例如，iRhythm Technologies 在 2025 年 2 月發布的「2024 會計年度第四季及全年財務表現」報告中指出，第四季營收為 1.643 億美元，年成長 24.0%，這主要得益於其 Zio攜帶式監測服務需求的激增。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

5. 全球心臟監測與心律管理設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 透過心臟監測設備（心電圖設備、植入式循環記錄器、攜帶式心電遙測設備、心摶出量監測設備等）
    • 依心臟節律管理裝置分類（去心房顫動與心律調節器）
    • 依最終使用者（醫院/診所、心臟護理中心、門診手術中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美心臟監測與心律管理設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲心臟監測與心律管理設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區心臟監測與心律管理設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東及非洲心臟監測及心律管理設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲心臟監測與心律管理設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

13. 全球心臟監測與心律管理設備市場：SWOT 分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Biotronik SE & Co. KG
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • GE Healthcare
  • MicroPort Scientific Corporation
  • LivaNova PLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7306

The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is projected to expand from USD 26.38 Billion in 2025 to USD 37.53 Billion by 2031, reflecting a compound annual growth rate of 6.05%. These technologies encompass medical devices designed to regulate heart activity or detect arrhythmias through electrical therapy or continuous tracking. The primary factors fueling this market trajectory are the growing prevalence of chronic cardiovascular diseases and an aging population necessitating constant physiological monitoring. As reported by the European Society of Cardiology in 2024, cardiovascular disease remained the leading cause of death across member nations, accounting for over 3 million annual fatalities. This substantial health burden highlights the critical need for therapeutic and diagnostic solutions capable of preventing adverse cardiac incidents.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 26.38 Billion
Market Size 2031USD 37.53 Billion
CAGR 2026-20316.05%
Fastest Growing SegmentECG Devices
Largest MarketNorth America

However, market expansion is significantly hindered by high product development costs and stringent reimbursement frameworks within various healthcare systems. These regulatory and financial obstacles frequently postpone the commercial introduction of novel technologies and limit patient access to sophisticated treatment options, particularly in cost-sensitive areas. Consequently, these hurdles create a complex environment where the speed of innovation is often tempered by economic and compliance-related constraints.

Market Driver

The escalating global prevalence of cardiovascular diseases and arrhythmias acts as the fundamental driver propelling the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market. As the burden of chronic heart conditions grows worldwide, there is an urgent necessity for early arrhythmia detection and continuous physiological tracking to lower mortality risks. This rising demand correlates strongly with the spread of lifestyle-associated risk factors, such as obesity, which severely exacerbate cardiovascular vulnerability. According to the World Heart Federation's 'World Heart Report 2025' published in May 2025, high body mass index is now responsible for nearly one in ten cardiovascular disease deaths globally, emphasizing the need for effective management. Additionally, the American Heart Association's '2025 Heart Disease and Stroke Statistics' from January 2025 noted that cardiovascular disease caused roughly 19.41 million deaths worldwide in 2021, highlighting the vast patient population requiring intervention.

Concurrently, a transition toward leadless and minimally invasive cardiac rhythm management solutions is transforming the market by providing safer, more patient-centric alternatives to conventional transvenous systems. Innovations like pulsed field ablation and leadless pacemakers are rapidly increasing in popularity because they minimize procedural complications and accelerate recovery times. This shift is fueling significant commercial growth as healthcare providers increasingly adopt these advanced, less invasive techniques. For instance, Boston Scientific reported in its 'Fourth Quarter and Full Year 2024 Results' in February 2025 that it achieved a 22.4 percent rise in fourth-quarter net sales, a surge driven largely by the swift adoption of its cutting-edge rhythm management and interventional cardiology portfolios.

Market Challenge

The extensive costs associated with product development and stringent reimbursement frameworks constitute a major obstacle to the expansion of the global market for cardiac monitoring and rhythm management devices. Creating complex Class III devices, such as continuous monitors and implantable cardioverter-defibrillators, necessitates substantial capital investment to satisfy clinical trial requirements and regulatory standards. When these demands are coupled with inflexible reimbursement policies that frequently limit or delay coverage for emerging technologies, manufacturers encounter significant financial strain. This economic pressure disincentivizes investment in innovation, compelling companies to allocate resources toward compliance rather than research and development, which ultimately decelerates the commercialization of vital cardiac solutions.

These regulatory and financial barriers directly constrain the availability of advanced treatments in critical regions. Manufacturers are increasingly delaying product introductions in markets characterized by complex compliance mandates to avoid incurring excessive costs. According to data from MedTech Europe in 2024, the percentage of major medical device manufacturers choosing the European Union as their primary launch geography fell by 33% because of the resource intensity and unpredictability of the regulatory landscape. Such deferrals in market entry hinder the growth of the global sector and restrict patient access to essential cardiac rhythm management therapies.

Market Trends

The integration of artificial intelligence for predictive analytics and real-time ECG analysis is fundamentally transforming diagnostic workflows by improving the accuracy and speed of arrhythmia detection. This technological advancement goes beyond basic data storage, employing deep learning algorithms to recognize subtle physiological patterns that conventional monitoring might miss, thus enabling earlier medical intervention. Regulatory authorities are increasingly validating these software-driven solutions, signaling broad sector confidence in algorithmic decision-making. As highlighted by Cardiovascular Business in the January 2025 article 'FDA has now cleared more than 1,000 AI models,' ten new cardiology-specific AI algorithms received approval within a recent two-month period, establishing the specialty as the second-largest field for algorithmic innovation.

Simultaneously, the move toward home-based monitoring solutions and remote cardiac telemetry is decentralizing care delivery, facilitating continuous patient oversight beyond clinical environments. This trend is propelled by the necessity to enhance patient compliance and decrease hospital readmissions through the use of unobtrusive, wearable patch technologies that transmit data directly to medical providers. The commercial success of these ambulatory platforms underscores the increasing dependence on extended, out-of-clinic diagnostic services. For example, iRhythm Technologies reported in its 'Fourth Quarter and Full Year 2024 Financial Results' in February 2025 that fourth-quarter revenue rose by 24.0% to $164.3 million, a growth primarily driven by the surging demand for its Zio ambulatory monitoring services.

Key Market Players

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Biotronik SE & Co. KG
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • GE Healthcare
  • MicroPort Scientific Corporation
  • LivaNova PLC

Report Scope

In this report, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Monitoring Devices

  • ECG Devices
  • Implantable Loop Recorders
  • Mobile Cardiac Telemetry Devices
  • Cardiac Output Monitoring Devices
  • Others

Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Rhythm Management Devices

  • Defibrillator v/s Pacemakers

Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By End User

  • Hospitals & Clinics
  • Cardiac Care Centers
  • Ambulatory Surgery Centers
  • Others

Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market.

Available Customizations:

Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Cardiac Monitoring Devices (ECG Devices, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, Cardiac Output Monitoring Devices, Others)
    • 5.2.2. By Cardiac Rhythm Management Devices (Defibrillator v/s Pacemakers)
    • 5.2.3. By End User (Hospitals & Clinics, Cardiac Care Centers, Ambulatory Surgery Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Cardiac Monitoring Devices
    • 6.2.2. By Cardiac Rhythm Management Devices
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Cardiac Monitoring Devices
        • 6.3.1.2.2. By Cardiac Rhythm Management Devices
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Cardiac Monitoring Devices
        • 6.3.2.2.2. By Cardiac Rhythm Management Devices
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Cardiac Monitoring Devices
        • 6.3.3.2.2. By Cardiac Rhythm Management Devices
        • 6.3.3.2.3. By End User

7. Europe Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Cardiac Monitoring Devices
    • 7.2.2. By Cardiac Rhythm Management Devices
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Cardiac Monitoring Devices
        • 7.3.1.2.2. By Cardiac Rhythm Management Devices
        • 7.3.1.2.3. By End User
    • 7.3.2. France Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Cardiac Monitoring Devices
        • 7.3.2.2.2. By Cardiac Rhythm Management Devices
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Cardiac Monitoring Devices
        • 7.3.3.2.2. By Cardiac Rhythm Management Devices
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Cardiac Monitoring Devices
        • 7.3.4.2.2. By Cardiac Rhythm Management Devices
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Cardiac Monitoring Devices
        • 7.3.5.2.2. By Cardiac Rhythm Management Devices
        • 7.3.5.2.3. By End User

8. Asia Pacific Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Cardiac Monitoring Devices
    • 8.2.2. By Cardiac Rhythm Management Devices
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Cardiac Monitoring Devices
        • 8.3.1.2.2. By Cardiac Rhythm Management Devices
        • 8.3.1.2.3. By End User
    • 8.3.2. India Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Cardiac Monitoring Devices
        • 8.3.2.2.2. By Cardiac Rhythm Management Devices
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Cardiac Monitoring Devices
        • 8.3.3.2.2. By Cardiac Rhythm Management Devices
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Cardiac Monitoring Devices
        • 8.3.4.2.2. By Cardiac Rhythm Management Devices
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Cardiac Monitoring Devices
        • 8.3.5.2.2. By Cardiac Rhythm Management Devices
        • 8.3.5.2.3. By End User

9. Middle East & Africa Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Cardiac Monitoring Devices
    • 9.2.2. By Cardiac Rhythm Management Devices
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Cardiac Monitoring Devices
        • 9.3.1.2.2. By Cardiac Rhythm Management Devices
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Cardiac Monitoring Devices
        • 9.3.2.2.2. By Cardiac Rhythm Management Devices
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Cardiac Monitoring Devices
        • 9.3.3.2.2. By Cardiac Rhythm Management Devices
        • 9.3.3.2.3. By End User

10. South America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Cardiac Monitoring Devices
    • 10.2.2. By Cardiac Rhythm Management Devices
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Cardiac Monitoring Devices
        • 10.3.1.2.2. By Cardiac Rhythm Management Devices
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Cardiac Monitoring Devices
        • 10.3.2.2.2. By Cardiac Rhythm Management Devices
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Cardiac Monitoring Devices
        • 10.3.3.2.2. By Cardiac Rhythm Management Devices
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Abbott Laboratories
  • 15.3. Boston Scientific Corporation
  • 15.4. Johnson & Johnson
  • 15.5. Biotronik SE & Co. KG
  • 15.6. Koninklijke Philips N.V.
  • 15.7. Siemens Healthineers AG
  • 15.8. GE Healthcare
  • 15.9. MicroPort Scientific Corporation
  • 15.10. LivaNova PLC

16. Strategic Recommendations

17. About Us & Disclaimer